Home/Filings/4/0001225208-17-004551
4//SEC Filing

BOSTON SCIENTIFIC CORP 4

Accession 0001225208-17-004551

$BSXCIK 0000885725operating

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 4:19 PM ET

Size

8.0 KB

Accession

0001225208-17-004551

Insider Transaction Report

Form 4
Period: 2017-02-23
Dawkins Keith D
Sr. VP, Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2017-02-23+1,83978,624 total
  • Tax Payment

    Common Stock

    2017-02-23$24.48/sh831$20,34377,793 total
  • Exercise/Conversion

    Deferred Stock Units

    2017-02-231,8395,518 total
    Exp: 2020-02-23Common Stock (1,839 underlying)
Footnotes (2)
  • [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  • [F2]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.

Documents

1 file

Issuer

BOSTON SCIENTIFIC CORP

CIK 0000885725

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000885725

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 4:19 PM ET
Size
8.0 KB